Logo image of PMAX

POWELL MAX LTD-CL A (PMAX) Stock Fundamental Analysis

USA - NASDAQ:PMAX - VGG7200G1182 - Common Stock

1.99 USD
+0.01 (+0.51%)
Last: 11/18/2025, 6:25:10 PM
1.86 USD
-0.13 (-6.53%)
After Hours: 11/18/2025, 6:25:10 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to PMAX. PMAX was compared to 237 industry peers in the Capital Markets industry. PMAX may be in some trouble as it scores bad on both profitability and health. PMAX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PMAX has reported negative net income.
PMAX Yearly Net Income VS EBIT VS OCF VS FCFPMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

PMAX has a Return On Assets of -64.18%. This is amonst the worse of the industry: PMAX underperforms 96.20% of its industry peers.
The Return On Equity of PMAX (-102.36%) is worse than 87.76% of its industry peers.
Industry RankSector Rank
ROA -64.18%
ROE -102.36%
ROIC N/A
ROA(3y)0.47%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PMAX Yearly ROA, ROE, ROICPMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

PMAX's Gross Margin of 42.02% is in line compared to the rest of the industry. PMAX outperforms 47.26% of its industry peers.
The Profit Margin and Operating Margin are not available for PMAX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PMAX Yearly Profit, Operating, Gross MarginsPMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 -40

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, PMAX has less shares outstanding
PMAX has a better debt/assets ratio than last year.
PMAX Yearly Shares OutstandingPMAX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 1M 2M 3M
PMAX Yearly Total Debt VS Total AssetsPMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 1.20, we must say that PMAX is in the distress zone and has some risk of bankruptcy.
PMAX has a Altman-Z score (1.20) which is comparable to the rest of the industry.
PMAX has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.18, PMAX is doing good in the industry, outperforming 75.11% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 1.2
ROIC/WACCN/A
WACCN/A
PMAX Yearly LT Debt VS Equity VS FCFPMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 1.27 indicates that PMAX should not have too much problems paying its short term obligations.
PMAX's Current ratio of 1.27 is in line compared to the rest of the industry. PMAX outperforms 57.81% of its industry peers.
PMAX has a Quick Ratio of 1.27. This is a normal value and indicates that PMAX is financially healthy and should not expect problems in meeting its short term obligations.
PMAX has a Quick ratio of 1.27. This is comparable to the rest of the industry: PMAX outperforms 58.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
PMAX Yearly Current Assets VS Current LiabilitesPMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

0

3. Growth

3.1 Past

PMAX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -342.17%.
PMAX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.77%.
EPS 1Y (TTM)-342.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1808.86%
Revenue 1Y (TTM)-25.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PMAX Yearly Revenue VS EstimatesPMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 10M 20M 30M 40M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PMAX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PMAX Price Earnings VS Forward Price EarningsPMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PMAX Per share dataPMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PMAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

POWELL MAX LTD-CL A

NASDAQ:PMAX (11/18/2025, 6:25:10 PM)

After market: 1.86 -0.13 (-6.53%)

1.99

+0.01 (+0.51%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.81%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.75M
Revenue(TTM)60.41M
Net Income(TTM)-38.44M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.74
P/FCF N/A
P/OCF N/A
P/B 1.19
P/tB 4.74
EV/EBITDA N/A
EPS(TTM)-2.51
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.69
BVpS1.67
TBVpS0.42
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -64.18%
ROE -102.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.02%
FCFM N/A
ROA(3y)0.47%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 1.2
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)16.17%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-342.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1808.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-336.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-289.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-260.44%
OCF growth 3YN/A
OCF growth 5YN/A

POWELL MAX LTD-CL A / PMAX FAQ

What is the fundamental rating for PMAX stock?

ChartMill assigns a fundamental rating of 1 / 10 to PMAX.


What is the valuation status for PMAX stock?

ChartMill assigns a valuation rating of 0 / 10 to POWELL MAX LTD-CL A (PMAX). This can be considered as Overvalued.


What is the profitability of PMAX stock?

POWELL MAX LTD-CL A (PMAX) has a profitability rating of 0 / 10.


How financially healthy is POWELL MAX LTD-CL A?

The financial health rating of POWELL MAX LTD-CL A (PMAX) is 3 / 10.